Catalina Vadell

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Felipe Cardenal, M.P. López-Cabrerizo, Antonio Antón et al. · Journal of Clinical Oncology · 1999 · 476 citations

Medicine, Oncology, Pharmacology +10

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

Francesc Graus, J Dalmou, R. Reñé et al. · Journal of Clinical Oncology · 1997 · 377 citations

Medicine, Neurology, Oncology +17

Cisplatin Plus Gemcitabine Versus a Cisplatin-Based Triplet Versus Nonplatinum Sequential Doublets in Advanced Non–Small-Cell Lung Cancer: A Spanish Lung Cancer Group Phase III Randomized Trial

V. Alberola, Carlos Camps, Mariano Provencio et al. · Journal of Clinical Oncology · 2003 · 193 citations

Medicine, Oncology, Pharmacology +14

Anticachectic Efficacy of Megestrol Acetate at Different Doses and Versus Placebo in Patients With Neoplastic Cachexia

Catalina Vadell, Miguel Ángel Seguí, José María Giménez-Arnau et al. · American Journal of Clinical Oncology · 1998 · 63 citations

Medicine, Oncology, Pharmacology +17

Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)

A. Antón, Nieves Díaz-Fernández, J.L. González-Larriba et al. · Lung Cancer · 1998 · 40 citations

Medicine, Oncology, Pharmacology +14